See all
 |
Articles: Stomach/GI |
Prior Articles
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09
Free full text
Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer
Oncology (Karger), 09/09/09 Pharmacogenomics in chemotherapy for GI tract cancer
Journal of Gastroenterology, 09/08/09 Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status
Alimentary Pharmacology and Therapeutics, 09/08/09 The use of gastrointestinal intubation studies for controlled release development
British Journal of Clinical Pharmacology, 09/08/09 Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines
Alimentary Pharmacology and Therapeutics, 09/08/09 Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab
Alimentary Pharmacology and Therapeutics, 09/08/09 New aspects of an anti-tumor drug: sorafenib efficiently inhibits HCV replication
Gut, 09/08/09 Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant
British Journal of Clinical Pharmacology, 09/08/09 Use of Over-the-Counter Analgesics Is Not Associated With Acute Decompensation in Patients With Cirrhosis
Clinical Gastroenterology and Hepatology, 09/04/09 Therapeutic potential of dithiolethiones for hepatic diseases
Pharmacology & Therapeutics, 09/04/09 Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides
Pharmacology & Therapeutics, 09/04/09 Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer
Pharmacoepidemiology and Drug Safety, 09/04/09 Cellular models for the screening and development of anti-hepatitis C virus agents
Pharmacology & Therapeutics, 09/04/09 The necessity of chemotherapy in T3N0M0 colon cancer without risk factors
The American Journal of Surgery, 09/03/09 Mesalazine for ulcerative colitis: evidence for use
Nurse Prescribing, 09/02/09 Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization
Pharmacoepidemiology and Drug Safety, 09/02/09 Decline in Male Sexual Desire, Function, and Satisfaction During and After Antiviral Therapy for Chronic Hepatitis C
Gastroenterology, 09/02/09 Definitive concomitant chemoradiotherapy with docetaxel and cisplatin in squamous esopheageal carcinoma
Diseases of the Esophagus, 09/02/09 Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation
Neurogastroenterology and Motility, 09/01/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|